CVGU.F CSPC PHARMACEUT.GR. ADR4

Healthcare Pharmaceuticals Frankfurt Exchange
3.58 EUR
Close of Nov 11, 2026
2.52 4.64
Market cap
EUR 10.2B
P/E
11.2x
P/B
2.04x
ROE
11.7%
Dividend yield
4.22%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is CVGU.F undervalued?

Graham number
Price3.58
Graham value3.55
Premium0.8%

CVGU.F trades 0.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CSPC PHARMACEUT.GR. ADR4 fundamental analysis

No fundamental analysis for CSPC PHARMACEUT.GR. ADR4 yet.

CSPC PHARMACEUT.GR. ADR4 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CSPC PHARMACEUT.GR. ADR4

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enx…

Full company profile